Inhaler
Latest AstraZeneca AB Patents:
- Substituted pyrazine-2-carboxamides as HPK1 inhibitors for the treatment of cancer
- Combination treatment by administering a recombinant apyrase protein in conjunction with a P2Yinhibitor
- Dry powder formulation for pulmonary delivery and methods of use
- POLQ inhibitors
- ORAL FORMULATION OF A THERAPEUTIC COMPOUND
The patent or application file contains at least one drawing executed in color. Copies of this patent or patent application publication with color drawing(s) will be provided by the Office upon request and payment of the necessary fee.
Claims
The ornamental design for an inhaler, as shown and described.
| D348929 | July 19, 1994 | Paton |
| D412744 | August 10, 1999 | Braithwaite |
| D439656 | March 27, 2001 | Andersson et al. |
| D449882 | October 30, 2001 | Christrup et al. |
| D509898 | September 20, 2005 | Bunce et al. |
| D582544 | December 9, 2008 | Meziere |
| D585541 | January 27, 2009 | Petersen |
| 7520278 | April 21, 2009 | Crowder et al. |
| D598536 | August 18, 2009 | Parkes |
| D620588 | July 27, 2010 | Nielsen |
| 20030192535 | October 16, 2003 | Christrup et al. |
| 20090084379 | April 2, 2009 | Goeckner et al. |
Type: Grant
Filed: Mar 9, 2012
Date of Patent: Nov 4, 2014
Assignee: AstraZeneca AB (Sodertalje)
Inventors: Rasmus Løgstrup Jensen (Aarhus), Thomas Aagaard Jensen (Aarhus)
Primary Examiner: Ian Simmons
Assistant Examiner: Richelle Shelton
Application Number: 29/415,300